stockrow
Friday 6 November 2026
Export SOLV’s income statement to Excel — free account
Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
91.06
3.88
+4.45%
Follow SOLV
Alert me
Solventum Corporation (SOLV) Operating cash flow
Solventum Corporation's operating cash flow for fiscal 2025 was $369.0M, down 68.9% from $1.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $310.0M. Solventum Corporation ranks 13th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $369.0M | (68.86%) |
| FY2024 | $1.2B | (38.12%) |
| FY2023 | $1.9B | 14.06% |
| FY2022 | $1.7B | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $177.0M | (22.03%) |
| Jun 2026 | $227.0M | — |
| Mar 2026 | −$189.0M | — |
| Dec 2025 | $95.0M | 25.00% |
| 12 more quarters | Free account |
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BAX Baxter International Inc. compare | $1.6B |
| COO The Cooper Companies, Inc. compare | $1.0B |
| ALGN Align Technology, Inc. compare | $749.9M |
| WST West Pharmaceutical Services, Inc. compare | $654.5M |
| AVTR Avantor, Inc. compare | $584.7M |
| ATR AptarGroup, Inc. compare | $573.5M |
| BLCO Bausch + Lomb Corporation compare | $554.0M |
| SOLV Solventum Corporation | $310.0M |
| RGEN Repligen Corporation compare | $129.9M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement